Fundraising Fox

Pedro Bueno

Investor

Partner at DNA Capital

Sao Paulo, Brazil

Writes $100K – $5M checks · typically $2.5M

About

Pedro Bueno is a partner at DNA Capital and serves as CEO of the company formed by the merger of diagnostics firm DASA and hospital chain Rede Ímpar, sitting on the boards of both. He started in investment banking at BTG Pactual working on M&A transactions, then joined Amil in 2012 and took part in its sale to UnitedHealth Group before becoming CEO of DASA. He holds a B.A. in Economics from Pontifícia Universidade Católica do Rio de Janeiro.

LinkedIn ↗

Invests in

Digital HealthHealthtech

Experience

  1. DasaVice-Presidente do Conselho de Administraçãocurrent2024 — present
  2. DasaPresidente2015 — 2024

Education

  1. Pontifícia Universidade Católica do Rio de JaneiroEconomia

Same school

Also attended Pontifícia Universidade Católica do Rio de Janeiro59

Abdul LyInvestor at Initialized CapitalAlexandre FlamantPartner at HCVCCarlos Alonso TorrasPartner at FinTech CollectiveJuliana BaranowskiHead of Platform at Astella InvestimentosFelipe MendesDirector of Finance Brazil at Valor Capital GroupDavid Pérez-HernándezPartner at Roble Ventures

+ 53 more

Shared employers

Also worked at Dasa3

Mario Sergio RibeiroInvestor at DNA CapitalRicardo SalomãoGeneral Partner at Greenrock CapitalAdam AlvesInvestor at Victoria Capital

Investments

Board seats

Localiza

Per the firm's website.

Colleagues at DNA Capital

Camila Guimarães
Investor at DNA Capital
Daniel Studart
Investor at DNA Capital
Gian Carlo Di Tommaso
Partner at DNA Capital
Henrique Bandeira
Investor at DNA Capital
José Eduardo Ribeiro Guinle
Investor at DNA Capital
Julia Prado
Investor at DNA Capital
Lucas Cortez
Investor at DNA Capital
Luiz Felipe D Martins Costa
Investor at DNA Capital